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Immunoblotting of rat myometrial membranes with an antiserum (SGl) which recognizes the a-subunits of both G,l 
and G,2 indicated the presence of detectable levels of an apparently single form of some 40 kDa. A second antiserum 
(LE2) specific for G,2 also recognized this protein, confirming its identity. Immunoblotting of the myometrial membranes 
with a series of antipeptide (OCl, IMl, ONl) and polyclonal (RV3) antisera, all of which recognize rat brain G,, pro- 
duced a more complex pattern. Antisera OCl and ON1 recognized a single polypeptide which essentially comigrated 
with rat brain G,. In contrast, antisera RV3 and IMI did not recognize the myometrial protein. These data provide evi- 
dence for the presence of Gi2 and of a novel G-protein, related immunologically to G,, in rat myometrial membranes. 
Guanine nucleotide-binding protein; Pertussis toxin; (Myometrium, Brain) 
1. INTRODUCTION 
The interaction of many hormones and 
neurotransmitters with specific receptors in the 
plasma membranes of target cells leads to altera- 
tions in levels of particular intracellular second 
messengers, In every case, communication between 
the agonist-occupied receptor and the second 
messenger generation system involves the 
obligatory participation of members of a family of 
guanine nucleotide-binding proteins [ 1,2]. 
The application of cDNA cloning technology to 
the field of transmembrane signalling has led to the 
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identification of a considerable number of these G- 
proteins [3-61. Because of the extreme homology 
between the individual G-proteins, conventional 
protein purification protocols have been unable to 
unambiguously identify products corresponding to 
each of the known cDNA clones. A convenient ap- 
proach to the detection of the individual G- 
proteins has thus been to produce antipeptide an- 
tisera which based on the predicted primary struc- 
tures of the different G-proteins should be able to 
discriminate between the various forms [7-91. 
We have previously produced a number of an- 
tipeptide antisera which are directed against 
distinct epitopes within the sequence of Go [lo]. G, 
is a member of the subfamily of G-proteins which 
are substrates for pertussis toxin-catalysed ADP- 
ribosylation [1,2] but despite the high concentra- 
tions of this protein in a number of tissues, 
especially brain and heart [11,12], its function re- 
mains a matter of debate [13,14] although it may 
well function to link receptors to voltage-sensitive 
Ca2+ channels. Recently it was noted that two in- 
dividual mRNAs could be identified on Northern 
analyses using a G, probe [4]. Here we 
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demonstrate the presence of a polypeptide in rat 
myometrial membranes which has some, but not 
all, of the immunological characteristics associated 
with G, from rat brain. We suggest that this pro- 
tein represents a novel G-protein which is im- 
munologically related to G,. We further 
demonstrate that myometrial membranes express 
high levels of Gi2. 
2. MATERIALS AND METHODS 
The sources of all materials used in this study have previously 
been recorded [14-16,181. 
2.1. Antibody production and characterization 
The antisera used in this study were as follows: antiserum 
OC! was raised in a New Zealand white rabbit against a 
glutaraldehyde conjugate of Keyhole limpet haemocyanin with 
a synthetic peptide (ANNLRGCGLY) corresponding to the C- 
terminal decapeptide of the u-subunit of G, [3,4]. Antisera 
ON! and IM! were produced in a similar fashion except hat the 
synthetic peptides wer NLKEDGISAAKDVK (amino acids 
22-35 of G& for antiserum IM! and GCTLSAEERAALERSK 
(amino acids 2-17 of G.=,u) for antiserum ON! [4]. Antiserum 
RV3 is a polyclonal antiserum raised against partially purified 
bovine brain G,. This antiserum contains populations of an- 
tibodies against both G,,cr and the &subunit. Production and 
characterization of this antiserum has previously been described 
[ll]. Antiserum SG! is an antipeptide antiserum produced 
against the same conjugate as we have previously used to raise 
antisera AS6 and AS7 [8,9]. These antisera recognize the (Y- 
subunits of the ‘Gt-like’ G-proteins, Gil and Gi2 [8,17]. The 
production of antiserum LE2 has previously been described [S]. 
This antiserum displays specificity for Gi2 [8]. 
2.2. Membrane preparations 
Membranes were prepared from the cerebral cortices of rat 
brain as previously described for other tissues [14,15]. 
Myometrial membranes were prepared from uteri obtained 
from estrogen-dominated rats as in [18]. Immunoblotting 
studies using the various antisera were performed, unless other- 
wise detailed, using 1: 200 dilutions of the primary antisera as 
previously described in some detail [8,10,16]. 
3. RESULTS 
Rat myometrial membranes have previously 
been shown to express significant levels of (a) per- 
Fig.!. Identification of the major Gi-like protein of rat myometrial membranes as Gi2. (A) Membranes from either rat brain (B) 
(1OO~g) or rat myometrium (M) (1OOrg) were resolved on an SDS-polyacrylamide gel (10% (w/v) acrylamide). Following 
electrophoretic transfer to nitrocellulose and blocking with 3% gelatin, the blot was incubated overnight with a 1:200 dilution of 
antiserum SG 1. The immunoblot was developed using 0-dianisidine following treatment with a horseradish peroxidase-linked onkey 
anti-rabbit second antibody. (B) A similar experiment o that described in A was performed except that the primary antiserum was 
a 1 :200 dilution of LE2, an antiserum specific for Gi2 [El. 
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tussis toxin-sensitive G-protein(s) of some 40 kDa 
[18]. However, the molecular identity of this 
(these) polypeptide(s) has not been established. We 
first used an antipeptide antiserum (SGl) capable 
of interacting with the a-subunits of the Gi-like 
proteins, Gil and Gi2 to probe Western blots of 
both brain and myometrial tissue from rats. Using 
this antiserum, membranes from rat brain could be 
shown to express two immunoreactive polypep- 
tides, a more prominent 41 kDa band (Gil) and a 
less prominent polypeptide with slightly greater 
mobility in the gels (Gi2) (fig.lA). In contrast, 
myometrial membranes at this level appeared to 
contain detectable quantities of only a single form 
of Gi (fig.lA). The use of the selective Gi2 (Y- 
antiserum, LE2, showed, as previously noted, that 
this polypeptide was present at only low levels in 
brain [8] but to be present in much higher levels in 
the myometrial membranes (fig.lB). These ex- 
periments thus also confirmed the identity of the 
rat myometrial Gi as Gi2. 
Experiments on the specificity of antiserum ON1 
demonstrated that it recognized a single polypep- 
tide of some 39 kDa in rat brain membranes and 
that this polypeptide migrated further in the gel 
than the predominant form of Gi in brain (Gil) as 
identified with antiserum SGl (fig.2). Im- 
munoblotting of rat brain membranes with a mix- 
ture of antisera SGl and ON1 further 
demonstrated that the polypeptides identified by 
these antisera were mutually exclusive (fig.2) hence 
confirming that these antisera do not display cross- 
reactivity. Further experiments with partially 
purified pertussis toxin-sensitive G-proteins from 
bovine brain confirmed these observations (results 
not shown). Similar experiments confirmed the 
specificity of antiserum OCl for G, (fig.3), whilst 
mixtures of antisera ON1 and OCl identified an 
Fig.2. Characterization of the specificity of antiserum ONl. Fig.3. Characterization of the specificity of antiserum OCl. Rat 
Rat brain membranes (50 pg) were resolved as in fig. 1 following brain membranes (50 pg) were resolved following alkylation as 
alkylation of the membranes with IV-ethyl maleimide as detailed described in fig.2 and transferred to nitrocellulose as in fig. 1. 
in [21]. The resultant blots were incubated with (a) antiserum Following blocking, the samples were treated with (a) antiserum 
SGl (1:300 dilution), (b) antiserum SGl (1:300 dilution) + SGl (1:300 dilution), (b) antiserum SC31 (I:300 dilution) + 
antiserum ON1 (1: 1500 dilution), or (c) antiserum ON1 antiserum OCl (1 : 1500 dilution), (c) antiserum OCl (1: 1500 
(1: 1500 dilution). The immunoblots were then developed as in dilution), (d) antiserum OCl (1: 1500 dilution) + antiserum 
fig.lA. The two antisera identified mutually exclusive ON1 (1: 1500 dilution). The immunoblots were then developed 
polypeptides. as in fig. 1. 
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apparently single polypeptide in rat brain (fig.3). 
Immunoblotting of rat myometrial membranes 
with both antiserum OCl and with antiserum ON1 
led to the identification of a single polypeptide of 
some 39 kDa which migrated with similar mobility 
to Gd in rat brain (fig.4). In a number of ex- 
periments, however, the myometrial protein was 
noted to have a slightly retarded mobility on SDS- 
PAGE in comparison to rat brain G,a (data not 
shown). In contrast, however, antiserum IMl did 
not identify a polypeptide of this size in the 
myometrial membranes (fig.4). Furthermore, the 
polyclonal antiserum RV3, which was produced 
using partially purified, holomeric bovine brain G, 
Fig.4. Immunological analysis of a form of G, in rat 
myometrial membranes. Rat brain (B) (5Ocg) and rat 
myometrial (M) membranes (200 pg) were resolved as in fig. 1 
and immunoblotted with 1:2OO dilutions of a range of 
antipeptide (a-c) or polyclonal (d) antisera against Go. Whilst 
each of the antisera, (a) ONl, (b) OCl, (c) IMl and (d) RV3 
identified a 39 kDa polypeptide in the rat brain membranes, 
only ON1 and OCl identified a polypeptide with similar, if 
Fig.5. Antisera ON1 and OCl do not identify Cit2. Membranes 
of rat glioma C6 BUl cells (50 pg) (1) and rat brain (50 pg) (2) 
were resolved on SDS-PAGE slab gels (12.5% acrylamide, 
0.15% bisacrylamide) as described in fig.3 and immunoblotted 
with (A) antiserum SO1 (1:200 dilution), (B) antiserum ON1 
(1 : 1000 dilution), (C) antiserum OCl (1: 1000 dilution). Whilst 
antiserum SGl identified Gt2 in C6 membranes and both Gil 
and Gt2 in brain, both OCl and ON1 identified only G, in brain 
and did not identify a polypeptide with mobility equivalent o 
slightly reduced, mobility in rat myometrial membranes. Gi2 in the C6 membranes. 
as antigen [ 1 l] equally did not identify the 39 kDa 
polypeptide in rat myometrial membranes 
although, as this antiserum also contains a popula- 
tion of antibodies directed against he P-subunit of 
G-proteins, it did identify a 36 kDa P-subunit in 
myometrium as well as in the brain membranes 
(fig.4). 
We wished to confirm that the polypeptide in 
myometrium identified by antisera OCl and ON1 
was not Gi2. We have previously demonstrated 
that rat glioma C6 BUl cells express high levels of 
Gi2 and that this is the predominant pertussis 
toxin-sensitive G-protein present in these cells [ 191. 
We thus immunoblotted membranes of C6 BUl 
cells and of rat brain, with each of antisera SGl, 
OCl or ONl, under SDS-PAGE conditions in 
12 12 12 
A 8' C 
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which good resolution of Gil, Gr2 and G, can be 
achieved (12.5% acrylamide, 0.15% bisacryl- 
amide). Antiserum SGl identified a single 
polypeptide of 40 kDa in C6 membranes (Gi2), but 
two polypeptides in rat brain, a 40 kDa polypep- 
tide which comigrated with Gi2 from C6 cells and 
a more prevalent polypeptide of 41 kDa (Gil) 
(fig.5). Both antisera OCl and ON1 identified a 
single band of 39 kDa in brain but failed to iden- 
tify a 40 kDa polypeptide in the C6 membranes. 
As such, these antisera do not cross-react with Gi2 
and thus the polypeptide identified by these an- 
tisera in rat myometrium is not Gr2. 
4. DISCUSSION 
The observation that pertussis toxin was able to 
catalyse ADP-ribosylation of the inhibitory G- 
protein of the adenylate cyclase cascade and conse- 
quently attenuate receptor-mediated inhibition of 
adenylate cyclase [20] provided a major advance in 
the understanding of hormonal regulation of 
second messenger generation and also provided a 
tool with which to identify Gr. However, with the 
purification of two pertussis toxin-sensitive G- 
proteins from bovine brain [21,22], and the subse- 
quent demonstrations that these proteins were at 
least immunologically [22,23], if not functionally 
[24] distinct, it became apparent hat a more selec- 
tive means of assessing the molecular identity of 
pertussis toxin-sensitive G-proteins was required. 
The further demonstration that neither antisera 
which selectively identified the major form of Gr 
(Gil) or Go from brain were able to cross-react 
with the major pertussis toxin-sensitive substrate in 
human neutrophils [25] or in rat glioma cells [26] 
further added to the complexity of the system. 
cDNA cloning studies have now identified at least 
6 potential G-protein a-subunit gene products 
which contain the characteristic signature of per- 
tussis toxin substrates, that is, a cysteine residue 
located 4 amino acids from the C-terminus [4]. 
These products are rod and cone specific forms of 
transducin, 3 forms of Gi (Gil, Gi2, Gi3) and G, 
[4]. There is no a priori reason to believe that this 
should represent he entire family of these proteins 
and more may yet be identified. 
The data reported herein demonstrate the 
presence of forms of both Gi and G, in the rat 
myometrium. In contrast to rat brain, where two 
distinct polypeptides (Gil, Gi2) can be identified 
with a ‘pan-Gi’ antiserum (SGl), we were able to 
detect considerable amounts of an apparently 
single immunoreactive polypeptide in rat myome- 
trium. This polypeptide was further identified with 
the Gi2 specific antiserum LE2 [8]. In this study we 
further demonstrate that G, may not represent a 
homogeneous population. This conclusion is based 
on the immunoreactivity of a series of antipeptide 
antisera which we have generated based on the 
predicted primary sequence of G, as derived from 
cDNA sequences for rat G, reported by both Itoh 
et al. [3] and Jones and Reed [4]. Two of these an- 
tipeptide antisera, directed against either the ex- 
treme C-terminus (OCl) or extreme N-terminus 
(ONl) of the a-subunit of G, identified a single 
polypeptide of some 39 kDa in rat myometrial 
membranes which had similar, if slightly reduced 
mobility, in SDS-polyacrylamide gels in com- 
parison with Go of rat brain. However, a third an- 
tipeptide G, antiserum (IMl), whilst identifying 
the same polypeptide in rat brain membranes as 
antisera OCl and ON1 did not identify the 
polypeptide present in the rat myometrial mem- 
branes. 
Intriguingly, a polyclonal antiserum (RV3) [ 1 l] 
raised against a mixture of pertussis toxin-sensitive 
G-proteins isolated from bovine brain [22], which 
we have previously characterised to contain 
populations of antibodies against both the cy- 
subunit of G, and against the P-subunit of G- 
proteins but not against he a-subunits of forms of 
Gi, did not identify the G, in rat myometrium but 
did identify the P-subunit. This is not a reflection 
of species diversity in G, as this polyclonal an- 
tiserum did identify rat brain G,. It might be an- 
ticipated that a polyclonal antiserum should 
possess populations of antibodies directed against 
different regions of a protein and as such should 
have at least some antibodies directed against areas 
in common if the forms of G, in brain and 
myometrium were markedly similar. However, this 
need not be so. We have previously characterised 
a polyclonal antiserum to rod transducin (CW6) 
[23] which cross-reacts with the major form of 
brain Gi (Gil), which on epitope mapping ap: 
peared to be directed against an epitope(s) within 
a very limited region of the protein [23,27]. This 
polyclonal antiserum shows little or no reactivity 
against he a-subunit of Gr2 [25,26] despite the fact 
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that Gil and Gi2 are some 88% homologous at the 
primary sequence level. In this particular case one 
region (epitope) of the protein appeared to be im- 
munodominant. This may be a reflection that the 
major areas of sequence diversity in the primary 
sequences of these two proteins are clustered and 
may represent areas (domains) involved in the con- 
tact of the G-protein with receptors and effector 
systems. As such, these areas must be exposed at 
the surface of the protein and hence potentially 
available to be recognized by the immune system. 
Whilst antiserum RV3 has not been epitope 
mapped in the same fashion, similar arguments 
may well apply. We have also noted that antiserum 
RV3 shows little or no immunoreactivity towards 
Go in membranes of rat white adipocytes ([16] and 
unpublished observations), whilst antiserum OCl 
identifies a 40 kDa polypeptide in this tissue (un- 
published observations). It is thus likely that this 
novel form of G, is not limited in distribution to 
the myometrium. 
In the light of the number of identified cDNA 
clones which presumptively code for pertussis 
toxin-sensitive G-proteins [4], it is of further in- 
terest to note that two mRNAs which hybridize 
with a G, probe have been identified [4]. Further, 
it has been possible to purify two separate forms of 
G, from bovine brain [28]. Based on im- 
munological characterization of each of these 
forms, however, it appears that they may represent 
no more than post-translationally modified forms 
of one another [28]. 
The observed complexity of the family of per- 
tussis toxin-sensitive G-proteins highlights the need 
for further selective means for their molecular 
identification. The burgeoning numbers of iden- 
tified G-proteins also implies that detailed 
biochemical analysis must be performed before 
specific functions can be attributed to the in- 
dividual forms. 
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